Rozas Rodrigo, Ortiz Andrea C, Peñaloza Sofía, Lizama Sebastián, Flores Mario E, Morales Javier, Arriagada Francisco
Departamento de Ciencias y Tecnología Farmacéutica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago 8380494, Chile.
Instituto de Farmacia, Facultad de Ciencias, Universidad Austral de Chile, Valdivia 5090000, Chile.
Pharmaceutics. 2025 May 25;17(6):694. doi: 10.3390/pharmaceutics17060694.
The absence of standardized protocols for assessing in vitro drug release from nanocarriers poses significant challenges in nanoformulation development. This study evaluated three in vitro methods: sample and separate without medium replacement (independent batch), sample and separate with medium replacement, and a dialysis bag method, to characterize the release of rhodamine B from mesoporous silica nanoparticles (MSNs). Each method was examined under varying agitation conditions (shaking versus stirring). MSNs were synthesized via the sol-gel method, exhibiting a hydrodynamic diameter of 202 nm, a zeta potential of -23.5 mV, and a surface area of 688 m/g, with a drug loading efficiency of 32.4%. Release profiles revealed that the independent batch method exhibited a rapid initial burst followed by a plateau after 4 h, attributed to surface saturation effects. Conversely, the sample and separate with medium replacement method sustained the release up to 60% over 48 h, maintaining sink conditions. The dialysis method showed agitation-dependent variability, with magnetic stirring using a longer stir bar enhancing release. Kinetic analyses indicated first-order kinetics with non-Fickian diffusion. Overall, the results indicate that both the selection of the in vitro method and the agitation technique play a crucial role in determining the apparent drug release kinetics from nanocarriers. These findings highlight the critical role of experimental design in interpreting nanocarrier release kinetics, advocating for tailored protocols to improve reproducibility and in vitro-in vivo correlations in nanoformulation.
缺乏用于评估纳米载体体外药物释放的标准化方案给纳米制剂的开发带来了重大挑战。本研究评估了三种体外方法:不更换介质的取样与分离(独立批次)、更换介质的取样与分离以及透析袋法,以表征罗丹明B从介孔二氧化硅纳米颗粒(MSN)中的释放情况。每种方法都在不同的搅拌条件下(振荡与搅拌)进行了考察。MSN通过溶胶 - 凝胶法合成,其流体动力学直径为202 nm,zeta电位为 -23.5 mV,表面积为688 m/g,载药效率为32.4%。释放曲线表明,独立批次法在初始阶段有快速的突释,4小时后达到平台期,这归因于表面饱和效应。相反,更换介质的取样与分离法在48小时内持续释放高达60%,维持了漏槽条件。透析法显示出与搅拌相关的变异性,使用较长搅拌棒的磁力搅拌可增强释放。动力学分析表明为一级动力学且伴有非菲克扩散。总体而言,结果表明体外方法的选择和搅拌技术在确定纳米载体的表观药物释放动力学方面都起着关键作用。这些发现突出了实验设计在解释纳米载体释放动力学中的关键作用,提倡采用定制方案以提高纳米制剂中重现性和体外 - 体内相关性。